Sacituzumab Govitecan – A Clinical Development Update Across Multiple Indications

Time: 9:40 am
day: Day One

Details:

  •  A brief introduction on the unique background of SG
  • Clinical update on metastatic TNBC
  • Clinical update on HR+ metastatic Breast Cancer
  •  Clinical update on metastatic Urothelial Cancer

Speakers: